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believe that this transsudate is fluid phase of bone marrow and
includes lipids (bone fat) from the internal volume of bones. It was
established, that bone fat contains mainly triglycerides (98%),
phospholipids (1.2%), small amount of cholesterol and high con-
tents of natural antioxidants - 2-4 mM. Using "polyethylene-metal"
friction pair friction coefficient was measured in present of some
biological fluids, including oily transsudate and bone fat. The
addition of the oily transsudate to the friction pair reduced fric-
tion coefficient 2-fold in comparison with effect of inflammatory
effusion. The most notable effect was observed with the bone fat
- friction coefficient decreases by 3.4 times. It was also revealed,
that introduction of the bone fat to synovial fluid essentially im-
proved its lubricating properties. In model experiment on the
sliding of a rabbit cartilage on a cartilage the influence of bone
fat under mechanical wear of articulate cartilage was studied.
During experiment the friction coefficient has grown from value
0.07 up to value 0.51. After the introduction of bone fat the friction
coefficient was reduced and remained at a near- normal level.
Conclusions: These results give the basis to believe about pos-
sible existence of arthro-medullary connection which participates
in the functioning of natural joints. The ligaments can play an
important role as a transport channels for the intrinsic joint lu-
bricant. Presence of antioxidant-bearing bone fat in a joint cavity
can improve considerably the sliding of the articulate cartilages,
inhibits formation of harmful reactive oxygen species and thus
promotes normal functioning of joints.
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Purpose: One of the key events in cartilage destruction in joint
diseases such as osteoarthritis is the degradation of the cartilage
collagen network. To support the development of novel therapies
for these diseases relevant preclinical models are needed to
study mechanisms of collagen degradation and synthesis. Ideally
these processes are studied in cartilage of human origin. How-
ever, due to the limited availability of human tissues, research is
often performed using for example bovine nasal cartilage and/or
isolated chondrocytes that are cultured in 3 dimensional matri-
ces. These methods are clearly useful, but would benefit from
an intermediate model that fills the gap to the human cartilage
explants. Therefore the aim of the current study was to setup
a bovine model for cytokine-induced articular cartilage degrada-
tion and characterize the model using a variety of compounds
targeting different disease mechanisms relevant to arthritis.
Methods: Full thickness articular cartilage punches ( 3.5 mm)
from the metacarpophalangeal joints of ± 6 months old calves
were cultured for 3 weeks in 96-well plates in the presence
P151 – Table 1 (#P < 0.05 versus unstimulated control explants; *P < 0.05 versus stimulated explants)
IL-1α Test compound % of initial Water content Denatured collagen GAG release Hyp release CTX-II release MMP activity COMP release
TNFα OSM wet weight % % % % % RFU/sec %
– – 115 76 11 35 1 5 0.9 48
+ – 91# 83# 17 82# 17# 89# 34# 74
+ Diclofenac 86 83 23 89 – 138 19 58
+ Dexamethasone 95 79* 11 91 – 5* 1.7* 63
+ Pioglitazon 87 83 27* 87 – 12* 12 97
+ Remicade 87 83 22 85 – 52 23 50
+ Risedronate 85 84 32* 84 – 95 23 48
+ Galardin 96 80* 12 90 – 5* 1.3* 43
+ A77-1726 94 79* 12 54* – 5* 1.7* 61
+ Kineret 103 78* 9* 51* – 5* 1.6* 31
or absence of a cytokine cocktail consisting of 10 ng/ml IL-
1α, 10 ng/ml TNFα and 10 ng/ml OSM. Culture medium was
refreshed weekly. After three weeks the cartilage and culture
medium were analyzed for weight changes, water content, DNA
content, glycosaminoglycans (GAG), hydroxyproline (Hyp), dam-
aged collagen molecules, MMP activity, C-telopeptide fragments
of Type II collagen (CTX-II) and cartilage oligomeric matrix pro-
tein (COMP). Diclofenac (10μM), Dexamethasone (0.5μM), Pi-
oglitazone (1μM), Remicade (10μg/ml), Risedronate (100μM),
Galardin (10μM) and A77-1726 (active metabolite of Lefluno-
mide; 100μM) were tested for their effect on cartilage degra-
dation. The experiment was performed on cartilage from three
different donors and with each test condition cultured in eight-fold
for each donor.
Results: Stimulation of the cartilage explants with a cytokine
cocktail resulted in changes that are also seen in human OA.
The weight of the explants was decreased compared to untreated
controls (24%, p < 0.01). Degradation of proteoglycans was
significantly increased by the cytokine treatment (47%, p < 0.01)
and could already be observed within 1 week after initiation of
the study. Collagen degradation (measured as Hyp and CTX-
II) was also significantly elevated, but this was seen only after
three weeks of culture. The collagen release was accompanied
by an increase in the amount of denatured collagen molecules
within the tissue (17% versus 11% in control cartilage; NS).
In accordance with the increased collagen damage, the water
content of the tissue was also increased (from 76% to 83%,
p < 0.01) which correlated with the collagen damage as well
(r = 0.88, P < 0.01). The level of active MMPs increased 40-fold
upon stimulation and correlated well with the collagen damage
(r = 0.99, P < 0.01). COMP release during the first week
of culture showed a trend towards up regulation during the
first week of culture for all three donors, this was however not
significant. A series of test compound was used to characterize
the response of the model to intervention, see table for details.
Conclusions: Stimulation of bovine articular cartilage explants
with a cocktail of IL-1α, TNFα and OSM results in clear and con-
sistent changes in the cartilage, highly reminiscent of cartilage
destruction during arthritis. The processes can be modulated by
one or more of the compounds tested, indicating that this model
for articular cartilage destruction is sensitive to treatment.
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Purpose: Chondroitin sulphate (CS) is a complex carbohydrate
polymer with variable sulphation which impacts function. Shark
